[Research and development for cancer biomarker]

Area of Science:

• Oncology
• Biomarker Research
• Personalized Medicine

Context:

• Cancer is a highly heterogeneous disease with variable patient responses to treatment.
• Personalized medicine aims to improve cancer care quality and reduce costs.
• Biomarker discovery is central to personalized cancer medicine, aiding screening, diagnosis, prognosis, and treatment prediction.

Purpose:

• To highlight the critical role of biomarker discovery and development in personalized cancer medicine.
• To outline essential requirements for efficient biomarker research, including clear endpoints, high-quality samples, and unbiased analysis.
• To emphasize the validation of biomarker candidates using independent datasets and the development of companion diagnostic kits.

Summary:

• Biomarker research, accelerated by high-throughput technologies, is crucial for tailoring cancer treatments.
• Key steps include defining biomarker endpoints, collecting well-characterized clinical samples, and performing unbiased high-throughput analysis.
• Rigorous validation of identified biomarkers and development of companion diagnostic kits are essential for clinical application.

Impact:

• Facilitates the advancement of personalized medicine for cancer patients.
• Enables more precise cancer screening, diagnosis, and prognosis.
• Supports the development of targeted therapies and companion diagnostics for improved treatment efficacy and safety.